Asthma: Drugs

(asked on 24th October 2014) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, how much the Government has spent on the development of new drugs to treat the symptoms of asthma in each of the last five years.


Answered by
George Freeman Portrait
George Freeman
This question was answered on 29th October 2014

The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.

£ million

2009-10

2010-11

2011-12

2012-13

2013-14

Asthma

Medical Research Council

6.6

5.3

4.5

3.6

5.4

Other Research Councils and Innovate UK

0.0

0.1

0.3

1.5

0.8

National Institute for Health Research

2.6

3.4

2.4

3.4

3.8

Total

9.2

8.8

7.2

8.5

10.0

Motor Neurone Research

Medical Research Council

7.0

7.5

4.2

4.1

3.6

Other Research Councils and Innovate UK

0.2

0.2

0.4

0.7

1.0

National Institute for Health Research

0.1

0.1

0.4

0.7

0.5

Total

7.3

7.8

5.0

5.5

5.1

Osteoporosis

Medical Research Council

6.2

5.4

5.1

4.6

5.9

Other Research Councils and Innovate UK

0.0

0.0

0.1

0.4

1.0

National Institute for Health Research

0.3

0.7

0.8

1.3

1.8

Total

6.5

6.1

6.0

6.3

8.7

The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.

Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.

Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.

Reticulating Splines